Overview

This new volume fills the gap in the literature as it will guide urologists and pathologists in the proper utilization of a variety of laboratory methods that are currently available to determine the presence, persistence or progression of tumors of the lower urinary tract. The volume emphasizes cytology of the urinary tract which is preferred over other methods (i.e. biochemical, immunological and cytogenetic) for its accuracy, especially for the important high grade tumors. This volume will appeal to urologists as well as pathologists, cytopathologists and related professions. The illustrations, nearly all in color, stress the key points of the text and enhance basic understanding of urothelial and other tumors of the urinary tract.

Full Product Details

Author:   Leopold G. Koss, MD, FCRP ,  Rana S. Hoda, MD, FIAC
Publisher:   Springer-Verlag New York Inc.
Imprint:   Springer-Verlag New York Inc.
Edition:   Softcover reprint of the original 1st ed. 2012
Weight:   0.454kg
ISBN:  

9781493952755

ISBN 10:   1493952757
Pages:   125
Publication Date:   23 August 2016
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Chapter 1- Introduction Chapter 2- Indication, Collection and Laboratory Processing of Cytologic Samples Principal Indication Collection Techniques Laboratory Processing of Samples Suggested Reading Chapter 3- The Cellular and Acellular Components of the Urinary Sediment Normal Urothelium (Transitional Epithelium) and Its Cells Other Benign Cells Noncellular Components of the Urinary Sediment Suggested Reading Chapter 4- The Cytologic Makeup of the Urinary Sediment According to the Collection Technique Voided urine Cytologic Makeup of Bladder Washings Cytologic Makeup of Normal Specimens Obtained by Retrograde Catheterization Cytologic Makeup of Smears Obtained by Brushing Cytologic Makeup of Ileal Bladder Urine Chapter 5- Cytologic Manifestations of Benign Disorders Affecting Cells of the Lower Urinary Tract Inflammatory disorders Cellular inclusions not due to viral agents Trematodes and other parasites Lithiasis Leukoplakia Effect of Drugs Effects of radiotherapy Monitoring of renal transplant patients Urinary Cytology in Renal Transplant Patients Rare benign conditions Suggested Reading Chapter 6- Tumors of the Bladder Non-Neoplastic Changes Hyperplasia Inverted papilloma Urothelial (Transitional) Cell Tumors Epidemiology Classification and natural history Types of Urothelial Tumors A. Papillary Urothelial Neoplasms I. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial Carcinoma B. Nonpapillary Urothelial Tumors I. Invasive Urothelial Carcinomas II. Flat Carcinoma In Situ (IUN III): Clinical Presentation, Histology Histologic Variants of Urothelial Carcinoma Metastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary Tract Reporting of cytologic findings Suggested Reading Chapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder Neoplasms Introduction US FDA-approved Markers Potential Markers in Earlier Phases of Clinical Development Markers Detected by Immunocytochemistry Comparison between Urine Cytology and FDA-approved Markers Conclusion References Chapter 4- The Cytologic Makeup of the Urinary Sediment According to the Collection Technique Voided urine Cytologic Makeup of Bladder Washings Cytologic Makeup of Normal Specimens Obtained by Retrograde Catheterization Cytologic Makeup of Smears Obtained by Brushing Cytologic Makeup of Ileal Bladder Urine Chapter 5- Cytologic Manifestations of Benign Disorders Affecting Cells of the Lower Urinary Tract Inflammatory disorders Cellular inclusions not due to viral agents Trematodes and other parasites Lithiasis Leukoplakia Effect of Drugs Effects of radiotherapy Monitoring of renal transplant patients Urinary Cytology in Renal Transplant Patients Rare benign conditions Suggested Reading Chapter 6- Tumors of the Bladder Non-Neoplastic Changes Hyperplasia Inverted papilloma Urothelial (Transitional) Cell Tumors Epidemiology Classification and natural history Types of Urothelial Tumors A. Papillary Urothelial Neoplasms I. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial Carcinoma B. Nonpapillary Urothelial Tumors I. Invasive Urothelial Carcinomas II. Flat Carcinoma In Situ (IUN III): Clinical Presentation, Histology Histologic Variants of Urothelial Carcinoma Metastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary Tract Reporting of cytologic findings Suggested Reading Chapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder Neoplasms Introduction US FDA-approved Markers Potential Markers in Earlier Phases of Clinical Development Markers Detected by Immunocytochemistry Comparison between Urine Cytology and FDA-approved Markers Conclusion References Cellular inclusions not due to viral agents Trematodes and other parasites Lithiasis Leukoplakia Effect of Drugs Effects of radiotherapy Monitoring of renal transplant patients Urinary Cytology in Renal Transplant Patients Rare benign conditions Suggested Reading Chapter 6- Tumors of the Bladder Non-Neoplastic Changes Hyperplasia Inverted papilloma Urothelial (Transitional) Cell Tumors Epidemiology Classification and natural history Types of Urothelial Tumors A. Papillary Urothelial Neoplasms I. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial Carcinoma B. Nonpapillary Urothelial Tumors I. Invasive Urothelial Carcinomas II. Flat Carcinoma In Situ (IUN III): Clinical Presentation, Histology Histologic Variants of Urothelial Carcinoma Metastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary Tract Reporting of cytologic findings Suggested Reading Chapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder Neoplasms Introduction US FDA-approved Markers Potential Markers in Earlier Phases of Clinical Development Markers Detected by Immunocytochemistry Comparison between Urine Cytology and FDA-approved Markers Conclusion References Chapter 4- The Cytologic Makeup of the Urinary Sediment According to the Collection Technique Voided urine Cytologic Makeup of Bladder Washings Cytologic Makeup of Normal Specimens Obtained by Retrograde Catheterization Cytologic Makeup of Smears Obtained by Brushing Cytologic Makeup of Ileal Bladder Urine Chapter 5- Cytologic Manifestations of Benign Disorders Affecting Cells of the Lower Urinary Tract Inflammatory disorders Cellular inclusions not due to viral agents Trematodes and other parasites Lithiasis Leukoplakia Effect of Drugs Effects of radiotherapy Monitoring of renal transplant patients Urinary Cytology in Renal Transplant Patients Rare benign conditions Suggested Reading Chapter 6- Tumors of the Bladder Non-Neoplastic Changes Hyperplasia Inverted papilloma Urothelial (Transitional) Cell Tumors Epidemiology Classification and natural history Types of Urothelial Tumors A. Papillary Urothelial Neoplasms I. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial Carcinoma B. Nonpapillary Urothelial Tumors I. Invasive Urothelial Carcinomas II. Flat Carcinoma In Situ (IUN III): Clinical Presentation, Histology Histologic Variants of Urothelial Carcinoma Metastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary Tract Reporting of cytologic findings Suggested Reading Chapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder Neoplasms Introduction US FDA-approved Markers Potential Markers in Earlier Phases of Clinical Development Markers Detected by Immunocytochemistry Comparison between Urine Cytology and FDA-approved Markers Conclusion References Cellular inclusions not due to viral agents Trematodes and other parasites Lithiasis Leukoplakia Effect of Drugs Effects of radiotherapy Monitoring of renal transplant patients Urinary Cytology in Renal Transplant Patients Rare benign conditions Suggested Reading Chapter 6- Tumors of the Bladder Non-Neoplastic Changes Hyperplasia Inverted papilloma Urothelial (Transitional) Cell Tumors Epidemiology Classification and natural history Types of Urothelial Tumors A. Papillary Urothelial Neoplasms I. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial Carcinoma B. Nonpapillary Urothelial Tumors I. Invasive Urothelial Carcinomas II. Flat Carcinoma In Situ (IUN III): Clinical Presentation, Histology Histologic Variants of Urothelial Carcinoma Metastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary Tract Reporting of cytologic findings Suggested Reading Chapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder Neoplasms Introduction US FDA-approved Markers Potential Markers in Earlier Phases of Clinical Development Markers Detected by Immunocytochemistry Comparison between Urine Cytology and FDA-approved Markers Conclusion References Cellular inclusions not due to viral agents Trematodes and other parasites Lithiasis Leukoplakia Effect of Drugs Effects of radiotherapy Monitoring of renal transplant patients Urinary Cytology in Renal Transplant Patients Rare benign conditions Suggested Reading Chapter 6- Tumors of the Bladder Non-Neoplastic Changes Hyperplasia Inverted papilloma Urothelial (Transitional) Cell Tumors Epidemiology Classification and natural history Types of Urothelial Tumors A. Papillary Urothelial Neoplasms I. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial Carcinoma B. Nonpapillary Urothelial Tumors I. Invasive Urothelial Carcinomas II. Flat Carcinoma In Situ (IUN III): Clinical Presentation, Histology Histologic Variants of Urothelial Carcinoma Metastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary Tract Reporting of cytologic findings Suggested Reading Chapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder Neoplasms Introduction US FDA-approved Markers Potential Markers in Earlier Phases of Clinical Development Markers Detected by Immunocytochemistry Comparison between Urine Cytology and FDA-approved Markers Conclusion References

Reviews

From the reviews: This is a comprehensive book on urinary tract cytology and clinical correlations. ... Written for cytologists and urologists, this book will be most appropriate for those in current practice, as well as those training in these fields. As for cytologists, both licensed cytologists and cytopathologists would find it useful. Lastly, clinical laboratory scientists or pathologists involved in urinalysis might find it helpful. ... This is a pretty cool book that you should have if you examine cytological preparations derived from urinary tract specimens. (Valerie Ng, Doody's Review Service, April/May, 2012) Cythopathology is helpful for screening, diagnosis and follow-up of patients with lower and upper urinary tract tumours. ... Cytologic aspects of such tumours were described, including urothelial, non urothelial, and metastatic. ... This textbook is wonderfully illustrated with color photographs, and represents an outstanding ... information, for cytologists, urologists, and oncologists. (European Urology Today, Issue 5, October/November, 2012) This book represents the concept of urine cytology in a compact, colourful crucible of high quality photomicrographs. It gives an excellent overview on the specific field of urine cytology. ... this book offers a practical approach to sampling techniques and cytological interpretation of urothelial malignancies. I would recommend this book to all laboratories where urine cytology forms an important component of the cytology practice. (Samita Agarwal, Urology News, March/April, 2013)

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions